000			01747 a2200457 4500
005			20250513160226.0
264		0	_c19990107
008			199901s 0 0 eng d
022			_a0022-3069
024	7		_a10.1097/00005072-199812000-00010 _2doi
040			_aNLM _beng _cNLM
100	1		_aSchmidt, R E
245	0	0	_aEffect of sorbitol dehydrogenase inhibition on experimental diabetic autonomic neuropathy. _h[electronic resource]
260			_bJournal of neuropathology and experimental neurology _cDec 1998
300			_a1175-89 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
650	0	4	_aAnimals
650	0	4	_aAutonomic Nervous System Diseases _xdrug therapy
650	0	4	_aBenzothiazoles
650	0	4	_aDiabetic Neuropathies _xdrug therapy
650	0	4	_aDrug Evaluation, Preclinical
650	0	4	_aEnzyme Inhibitors _xtherapeutic use
650	0	4	_aGanglia, Sympathetic _xdrug effects
650	0	4	_aL-Iditol 2-Dehydrogenase _xantagonists & inhibitors
650	0	4	_aMale
650	0	4	_aMesentery _xinnervation
650	0	4	_aNeuroaxonal Dystrophies _xdrug therapy
650	0	4	_aPhthalazines _xtherapeutic use
650	0	4	_aPiperazines _xtherapeutic use
650	0	4	_aPyrimidines _xtherapeutic use
650	0	4	_aRats
650	0	4	_aRats, Sprague-Dawley
650	0	4	_aThiazoles _xtherapeutic use
700	1		_aDorsey, D A
700	1		_aBeaudet, L N
700	1		_aPlurad, S B
700	1		_aWilliamson, J R
700	1		_aIdo, Y
773	0		_tJournal of neuropathology and experimental neurology _gvol. 57 _gno. 12 _gp. 1175-89
856	4	0	_uhttps://doi.org/10.1097/00005072-199812000-00010 _zAvailable from publisher's website
999			_c9825421 _d9825421